1,043
Views
0
CrossRef citations to date
0
Altmetric
Cardiology & Cardiovascular Disorders

Induced myocardial ischemia in candidates to liver transplantation without evidence of heart disease

, , , , , , , , , , , , , , , , , , , , , , ORCID Icon & show all
Article: 2237521 | Received 20 Apr 2023, Accepted 12 Jul 2023, Published online: 26 Jul 2023

References

  • Halvorsen S, Mehilli J, Cassese S, et al. 2022 ESC guidelines on cardiovascular assessment and management of patients undergoing non-cardiac surgery. Eur Heart J. 2022;43(39):1–11. doi: 10.1093/eurheartj/ehac270.
  • Lee MS. Diagnostic yield of coronary angiography in asymptomatic orthotopic liver transplantation candidates. Cardiovasc Revasc Med. 2022;35:59–63. doi: 10.1016/j.carrev.2021.03.004.
  • Lekerika N, Gutierrez Rico RM, Arco Vazquez J, et al. Predicting fluid responsiveness in patients undergoing orthotopic liver transplantation: effects on intraoperative blood transfusion and postoperative complications. Transplant Proc. 2014;46(9):3087–3091. doi: 10.1016/j.transproceed.2014.10.005.
  • Palanisamy AP, Nadig SN, Chedister GR, et al. Use of intra-aortic counterpulsation in cardiogenic shock post-liver transplantation. Clin Transplant. 2017;31(7). doi: 10.1111/ctr.13002.
  • Lee SS. Cardiac abnormalities in liver cirrhosis. West J Med. 1989;151(5):530–535.
  • Tarantini G, Nai Fovino L. TAVR versus SAVR in patients with severe aortic stenosis and concomitant end stage liver disease: when less is more. Catheter Cardiovasc Interv. 2020;96(4):956–957. doi: 10.1002/ccd.29291.
  • Johnston SD, Morris JK, Cramb R, et al. Cardiovascular morbidity and mortality after orthotopic liver transplantation. Transplantation. 2002;73(6):901–906. doi: 10.1097/00007890-200203270-00012.
  • Darstein F, Hoppe-Lotichius M, Vollmar J, et al. Pretransplant coronary artery disease is a predictor for myocardial infarction and cardiac death after liver transplantation. Eur J Intern Med. 2018;51:41–45. doi: 10.1016/j.ejim.2017.12.001.
  • Schoening WN, Buescher N, Rademacher S, et al. Twenty-year longitudinal follow-up after orthotopic liver transplantation: a single-center experience of 313 consecutive cases. Am J Transplant. 2013;13(9):2384–2394. doi: 10.1111/ajt.12384.
  • Kwong AJ, Ebel NH, Kim WR, et al. OPTN/SRTR 2020 annual data report: liver. Am J Transplant. 2022;22(Suppl. 2):204–309. doi: 10.1111/ajt.16978.
  • Kutkut I, Rachwan RJ, Timsina LR, et al. Pre-liver transplant cardiac catheterization is associated with low rate of myocardial infarction and cardiac mortality. Hepatology. 2020;72(1):240–256. doi: 10.1002/hep.31023.
  • Madhwal S, Atreja A, Albeldawi M, et al. Is liver transplantation a risk factor for cardiovascular disease? A meta-analysis of observational studies. Liver Transpl. 2012;18(10):1140–1146. doi: 10.1002/lt.23508.
  • Nayagam JS, Norton BC, Belete S, et al. Invasive coronary angiography as a tool in cardiac evaluation for liver transplant candidates. J Liver Transplant. 2022;7:100100. doi: 10.1016/j.liver.2022.100100.
  • Murray KF, Carithers RLJr., AASLD. AASLD practice guidelines: evaluation of the patient for liver transplantation. Hepatology. 2005;41(6):1407–1432. doi: 10.1002/hep.20704.
  • Doytchinova AT, Feigenbaum TD, Pondicherry-Harish RC, et al. Diagnostic performance of dobutamine stress echocardiography in end-stage liver disease. JACC Cardiovasc Imaging. 2019;12(11 Pt 1):2115–2122. doi: 10.1016/j.jcmg.2018.10.031.
  • Findlay JY, Keegan MT, Pellikka PP, et al. Preoperative dobutamine stress echocardiography, intraoperative events, and intraoperative myocardial injury in liver transplantation. Transplant Proc. 2005;37(5):2209–2213. doi: 10.1016/j.transproceed.2005.03.023.
  • Umphrey LG, Hurst RT, Eleid MF, et al. Preoperative dobutamine stress echocardiographic findings and subsequent short-term adverse cardiac events after orthotopic liver transplantation. Liver Transpl. 2008;14(6):886–892. doi: 10.1002/lt.21495.
  • Kim MY, Baik SK, Won CS, et al. Dobutamine stress echocardiography for evaluating cirrhotic cardiomyopathy in liver cirrhosis. Korean J Hepatol. 2010;16(4):376–382. doi: 10.3350/kjhep.2010.16.4.376.
  • Tsutsui JM, Mukherjee S, Elhendy A, et al. Value of dobutamine stress myocardial contrast perfusion echocardiography in patients with advanced liver disease. Liver Transpl. 2006;12(4):592–599. doi: 10.1002/lt.20651.
  • Stocker TJ, Deseive S, Leipsic J, et al. Reduction in radiation exposure in cardiovascular computed tomography imaging: results from the PROspective multicenter registry on radiaTion dose estimates of cardiac CT angIOgraphy in daily practice in 2017 (PROTECTION VI). Eur Heart J. 2018;39(41):3715–3723. doi: 10.1093/eurheartj/ehy546.
  • Paech DC, Weston AR. A systematic review of the clinical effectiveness of 64-slice or higher computed tomography angiography as an alternative to invasive coronary angiography in the investigation of suspected coronary artery disease. BMC Cardiovasc Disord. 2011;11:32. doi: 10.1186/1471-2261-11-32.
  • Steinkohl F, Barbieri F, Senoner T, et al. Coronary atherosclerosis profile in patients with end-stage liver disease prior to liver transplantation due to alcoholic fatty liver: a coronary CTA study. Eur Radiol. 2021;31(1):494–503. doi: 10.1007/s00330-020-07037-8.
  • Loffler AI, Gonzalez JA, Sundararaman SK, et al. Coronary computed tomography angiography demonstrates a high burden of coronary artery disease despite low-risk nuclear studies in pre-liver transplant evaluation. Liver Transpl. 2020;26(11):1398–1408. doi: 10.1002/lt.25869.
  • Montalescot G, Sechtem U, Achenbach S, et al. ESC guidelines on the management of stable coronary artery disease: the task force on the management of stable coronary artery disease of the European Society of Cardiology. Eur Heart J. 2013;34(38):2949–3003.
  • Bosner S, Haasenritter J, Becker A, et al. Ruling out coronary artery disease in primary care: development and validation of a simple prediction rule. CMAJ. 2010;182(12):1295–1300. doi: 10.1503/cmaj.100212.
  • Morgul MH, Felgendreff P, Kienlein A, et al. Milan criteria in the MELD era—is it justifiable to extend the limits for orthotopic liver transplantation? World J Surg Oncol. 2020;18(1):158. doi: 10.1186/s12957-020-01932-6.
  • Malik MU, Russell SD, Pustavoitau A, et al. The predictors of post-transplant coronary events among liver transplant recipients. Hepatol Int. 2016;10(6):974–982. doi: 10.1007/s12072-016-9742-5.
  • Dangl M, Eisenberg T, Grant JK, et al. A comprehensive review of coronary artery disease in patients with end-stage liver disease. Transplant Rev. 2022;36(3):100709. doi: 10.1016/j.trre.2022.100709.
  • Case BC, Yang M, Qamer SZ, et al. Pre-operative cardiovascular testing before liver transplantation. Am J Cardiol. 2021;152:132–137. doi: 10.1016/j.amjcard.2021.04.012.
  • An J, Shim JH, Kim SO, et al. Prevalence and prediction of coronary artery disease in patients with liver cirrhosis: a registry-based matched case-control study. Circulation. 2014;130(16):1353–1362. doi: 10.1161/CIRCULATIONAHA.114.009278.
  • Harinstein ME, Flaherty JD, Ansari AH, et al. Predictive value of dobutamine stress echocardiography for coronary artery disease detection in liver transplant candidates. Am J Transplant. 2008;8(7):1523–1528. doi: 10.1111/j.1600-6143.2008.02276.x.
  • Fleisher LA, Fleischmann KE, Auerbach AD, et al. ACC/AHA guideline on perioperative cardiovascular evaluation and management of patients undergoing noncardiac surgery: executive summary: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines. Circulation. 2014;130(24):2215–2245. doi: 10.1161/CIR.0000000000000105.
  • Rudziński PN, Kruk M, Kępka C, et al. The value of coronary artery computed tomography as the first-line anatomical test for stable patients with indications for invasive angiography due to suspected coronary artery disease: CAT-CAD randomized trial. J Cardiovasc Comput Tomogr. 2018;12(6):472–479. doi: 10.1016/j.jcct.2018.08.004.
  • Rudziński PN, Kruk M, Kępka C, et al. Assessing the value of coronary artery computed tomography as the first-line anatomical test for stable patients with indications for invasive angiography due to suspected coronary artery disease. Initial cost analysis in the CAT-CAD randomized trial. J Cardiovasc Comput Tomogr. 2020;14(1):75–79. doi: 10.1016/j.jcct.2019.07.008.
  • Rudziński PN, Kruk M, Demkow M, et al. Efficacy and safety of coronary computed tomography angiography in patients with a high clinical likelihood of obstructive coronary artery disease. Kardiol Pol. 2022;80(1):56–63. doi: 10.33963/KP.a2021.0185.
  • Cook CM, Petraco R, Shun-Shin MJ, et al. Diagnostic accuracy of computed tomography-derived fractional flow reserve: a systematic review. JAMA Cardiol. 2017;2(7):803–810. doi: 10.1001/jamacardio.2017.1314.
  • Tang CX, Qiao HY, Zhang XL, et al. Functional CAD-RADS using FFR(CT) on therapeutic management and prognosis in patients with coronary artery disease. Eur Radiol. 2022;32(8):5210–5221. doi: 10.1007/s00330-022-08618-5.
  • Nicolau-Raducu R, Gitman M, Ganier D, et al. Adverse cardiac events after orthotopic liver transplantation: a cross-sectional study in 389 consecutive patients. Liver Transpl. 2015;21(1):13–21. doi: 10.1002/lt.23997.
  • Główczyńska R, Galas M, Witkowska A, et al. The pre-transplant profile of cardiovascular risk factors and its impact on long-term mortality after liver transplantation. Ann Transplant. 2018;23:591–597. doi: 10.12659/AOT.908771.
  • Martin P, DiMartini A, Feng S, et al. Evaluation for liver transplantation in adults: 2013 practice guideline by the American Association for the study of liver diseases and the American Society of Transplantation. Hepatology. 2014;59(3):1144–1165. doi: 10.1002/hep.26972.
  • European Association for the Study of the Liver. EASL clinical practice guidelines: liver transplantation. J Hepatol. 2016;64(2):433–485.
  • VanWagner LB, Harinstein ME, Runo JR, et al. Multidisciplinary approach to cardiac and pulmonary vascular disease risk assessment in liver transplantation: an evaluation of the evidence and consensus recommendations. Am J Transplant. 2018;18(1):30–42. doi: 10.1111/ajt.14531.
  • Cheng XS, VanWagner LB, Costa SP, et al. Emerging evidence on coronary heart disease screening in kidney and liver transplantation candidates: a scientific statement from the American Heart Association: endorsed by the American Society of Transplantation. Circulation. 2022;146(21):e299–e324. doi: 10.1161/CIR.0000000000001104.
  • McCarthy KJ, Motta-Calderon D, Estrada-Roman A, et al. Introduction of a standardized protocol for cardiac risk assessment in candidates for liver transplant – a retrospective cohort analysis. Ann Hepatol. 2022;27(2):100582. doi: 10.1016/j.aohep.2021.100582.